Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 68 | 2024 | 5127 | 4.070 |
Why?
|
Catheter Ablation | 51 | 2024 | 2751 | 3.540 |
Why?
|
Cardiac Resynchronization Therapy | 20 | 2019 | 555 | 3.400 |
Why?
|
Cardiac Pacing, Artificial | 21 | 2020 | 866 | 2.080 |
Why?
|
Electric Countershock | 9 | 2023 | 533 | 2.040 |
Why?
|
Defibrillators, Implantable | 21 | 2024 | 1490 | 1.970 |
Why?
|
Anti-Arrhythmia Agents | 13 | 2024 | 774 | 1.890 |
Why?
|
Atrial Appendage | 9 | 2024 | 283 | 1.530 |
Why?
|
Heart Failure | 35 | 2021 | 11671 | 1.520 |
Why?
|
Cardiac Resynchronization Therapy Devices | 7 | 2018 | 122 | 1.490 |
Why?
|
Heart Ventricles | 24 | 2019 | 3807 | 1.420 |
Why?
|
Electrocardiography | 27 | 2019 | 6377 | 1.380 |
Why?
|
Body Surface Potential Mapping | 12 | 2015 | 228 | 1.350 |
Why?
|
Pulmonary Veins | 14 | 2024 | 743 | 1.350 |
Why?
|
Heart Conduction System | 12 | 2020 | 1007 | 1.060 |
Why?
|
Arrhythmias, Cardiac | 14 | 2022 | 2244 | 1.050 |
Why?
|
Death, Sudden, Cardiac | 7 | 2023 | 1555 | 0.970 |
Why?
|
Ventricular Fibrillation | 4 | 2024 | 537 | 0.890 |
Why?
|
Pacemaker, Artificial | 9 | 2019 | 807 | 0.890 |
Why?
|
Internal Medicine | 2 | 2021 | 1051 | 0.880 |
Why?
|
Digoxin | 1 | 2024 | 246 | 0.850 |
Why?
|
Tachycardia, Ventricular | 9 | 2024 | 1304 | 0.850 |
Why?
|
Defibrillators | 1 | 2023 | 39 | 0.850 |
Why?
|
Heart Atria | 12 | 2019 | 1345 | 0.850 |
Why?
|
Brugada Syndrome | 2 | 2015 | 93 | 0.780 |
Why?
|
Heart Rate | 12 | 2020 | 4195 | 0.770 |
Why?
|
Electrophysiologic Techniques, Cardiac | 10 | 2019 | 506 | 0.660 |
Why?
|
Ventricular Dysfunction | 1 | 2019 | 144 | 0.640 |
Why?
|
Specialty Boards | 1 | 2020 | 235 | 0.630 |
Why?
|
Atrioventricular Block | 1 | 2019 | 133 | 0.590 |
Why?
|
Certification | 1 | 2021 | 418 | 0.580 |
Why?
|
Anticoagulants | 10 | 2024 | 4812 | 0.570 |
Why?
|
Ventricular Remodeling | 5 | 2019 | 1267 | 0.570 |
Why?
|
Chaperonin 60 | 1 | 2016 | 97 | 0.540 |
Why?
|
Primary Prevention | 2 | 2023 | 1186 | 0.530 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 823 | 0.500 |
Why?
|
Insurance Claim Review | 1 | 2019 | 741 | 0.480 |
Why?
|
Cardiography, Impedance | 1 | 2014 | 40 | 0.470 |
Why?
|
Treatment Outcome | 56 | 2024 | 64685 | 0.460 |
Why?
|
Dextrocardia | 2 | 2010 | 37 | 0.460 |
Why?
|
Calcium Channel Blockers | 1 | 2017 | 694 | 0.450 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2019 | 2118 | 0.450 |
Why?
|
Long QT Syndrome | 2 | 2010 | 467 | 0.450 |
Why?
|
Bundle-Branch Block | 2 | 2015 | 276 | 0.430 |
Why?
|
Transducers, Pressure | 3 | 2019 | 51 | 0.420 |
Why?
|
Surgery, Computer-Assisted | 6 | 2015 | 1007 | 0.410 |
Why?
|
Humans | 156 | 2024 | 761596 | 0.410 |
Why?
|
Cardiac Surgical Procedures | 3 | 2019 | 3627 | 0.410 |
Why?
|
Stroke | 10 | 2024 | 9758 | 0.400 |
Why?
|
Electrodes, Implanted | 9 | 2012 | 840 | 0.390 |
Why?
|
Pulmonary Edema | 1 | 2014 | 409 | 0.380 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1241 | 0.380 |
Why?
|
Imaging, Three-Dimensional | 5 | 2013 | 4062 | 0.380 |
Why?
|
Coronary Thrombosis | 2 | 2011 | 440 | 0.380 |
Why?
|
Angioplasty, Balloon, Laser-Assisted | 1 | 2011 | 20 | 0.380 |
Why?
|
Societies, Medical | 1 | 2023 | 3905 | 0.370 |
Why?
|
Electrocardiography, Ambulatory | 5 | 2020 | 578 | 0.360 |
Why?
|
Atrial Flutter | 4 | 2017 | 252 | 0.360 |
Why?
|
Epicardial Mapping | 1 | 2010 | 58 | 0.360 |
Why?
|
Mitochondrial Proteins | 1 | 2016 | 976 | 0.360 |
Why?
|
Accessory Atrioventricular Bundle | 1 | 2011 | 58 | 0.360 |
Why?
|
Fluoroscopy | 3 | 2013 | 947 | 0.360 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2010 | 65 | 0.350 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2015 | 575 | 0.350 |
Why?
|
Aged | 72 | 2024 | 169310 | 0.340 |
Why?
|
Cardiomyopathies | 5 | 2019 | 1964 | 0.340 |
Why?
|
Hypothyroidism | 1 | 2015 | 668 | 0.340 |
Why?
|
Therapeutic Irrigation | 3 | 2021 | 292 | 0.340 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 148 | 0.340 |
Why?
|
Antiphospholipid Syndrome | 1 | 2011 | 165 | 0.340 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2011 | 123 | 0.330 |
Why?
|
Myocardial Ischemia | 8 | 2020 | 2113 | 0.330 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2000 | 489 | 0.320 |
Why?
|
Saphenous Vein | 1 | 2012 | 516 | 0.320 |
Why?
|
Male | 103 | 2024 | 360846 | 0.310 |
Why?
|
Aneurysm | 1 | 2012 | 337 | 0.310 |
Why?
|
Bradycardia | 1 | 2010 | 299 | 0.300 |
Why?
|
Esophagus | 5 | 2013 | 1033 | 0.300 |
Why?
|
Magnetic Resonance Angiography | 5 | 2015 | 1432 | 0.300 |
Why?
|
Prosthesis Implantation | 6 | 2017 | 592 | 0.290 |
Why?
|
Heart Injuries | 3 | 2019 | 206 | 0.290 |
Why?
|
Fever | 1 | 2015 | 1618 | 0.290 |
Why?
|
Body Temperature | 4 | 2015 | 781 | 0.290 |
Why?
|
Coronary Vessel Anomalies | 1 | 2010 | 307 | 0.290 |
Why?
|
Angina Pectoris, Variant | 1 | 2006 | 53 | 0.280 |
Why?
|
Follow-Up Studies | 23 | 2019 | 39106 | 0.270 |
Why?
|
Monitoring, Physiologic | 3 | 2019 | 1779 | 0.270 |
Why?
|
Radiation Dosage | 3 | 2013 | 1958 | 0.270 |
Why?
|
Female | 93 | 2024 | 392705 | 0.270 |
Why?
|
Pericardium | 1 | 2011 | 675 | 0.270 |
Why?
|
Echocardiography | 11 | 2019 | 4989 | 0.260 |
Why?
|
Equipment Design | 9 | 2018 | 3511 | 0.250 |
Why?
|
Coronary Artery Bypass | 2 | 2012 | 2188 | 0.250 |
Why?
|
Cryosurgery | 1 | 2010 | 474 | 0.250 |
Why?
|
Heart | 5 | 2019 | 4404 | 0.250 |
Why?
|
Patient Readmission | 1 | 2019 | 3271 | 0.250 |
Why?
|
Incidence | 13 | 2024 | 21355 | 0.240 |
Why?
|
Ventricular Premature Complexes | 2 | 2021 | 112 | 0.240 |
Why?
|
Disease Management | 2 | 2016 | 2508 | 0.240 |
Why?
|
Prognosis | 14 | 2021 | 29629 | 0.240 |
Why?
|
Middle Aged | 65 | 2024 | 220921 | 0.240 |
Why?
|
Torsades de Pointes | 1 | 2005 | 78 | 0.240 |
Why?
|
Sensitivity and Specificity | 12 | 2018 | 14665 | 0.230 |
Why?
|
Thromboembolism | 2 | 2023 | 995 | 0.230 |
Why?
|
Heart Block | 1 | 2005 | 386 | 0.230 |
Why?
|
Radiography, Thoracic | 3 | 2010 | 1302 | 0.220 |
Why?
|
Stroke Volume | 8 | 2019 | 5496 | 0.220 |
Why?
|
Postoperative Complications | 10 | 2020 | 15633 | 0.220 |
Why?
|
Computer Simulation | 1 | 2017 | 6241 | 0.220 |
Why?
|
Myocardial Contraction | 2 | 2005 | 1515 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2811 | 0.210 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1927 | 0.210 |
Why?
|
Signal Processing, Computer-Assisted | 4 | 2019 | 1496 | 0.210 |
Why?
|
Algorithms | 9 | 2019 | 14033 | 0.210 |
Why?
|
Angina Pectoris | 1 | 2006 | 959 | 0.210 |
Why?
|
Physicians | 1 | 2020 | 4591 | 0.210 |
Why?
|
Hospitalization | 9 | 2021 | 10721 | 0.200 |
Why?
|
Reproducibility of Results | 12 | 2018 | 20100 | 0.200 |
Why?
|
Hemodynamics | 2 | 2018 | 4160 | 0.200 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2015 | 1875 | 0.200 |
Why?
|
Risk Assessment | 14 | 2020 | 23996 | 0.200 |
Why?
|
Heart Transplantation | 5 | 2015 | 3233 | 0.190 |
Why?
|
Cardiotonic Agents | 1 | 2024 | 539 | 0.180 |
Why?
|
Coronary Angiography | 6 | 2010 | 4471 | 0.180 |
Why?
|
Swine | 10 | 2019 | 5915 | 0.180 |
Why?
|
Retrospective Studies | 28 | 2024 | 80647 | 0.180 |
Why?
|
Atherosclerosis | 1 | 2016 | 3407 | 0.180 |
Why?
|
Equipment Failure | 4 | 2011 | 578 | 0.180 |
Why?
|
Action Potentials | 5 | 2020 | 1834 | 0.180 |
Why?
|
Refractory Period, Electrophysiological | 1 | 2020 | 40 | 0.180 |
Why?
|
United States | 16 | 2024 | 72340 | 0.180 |
Why?
|
Feasibility Studies | 9 | 2015 | 5247 | 0.180 |
Why?
|
Treatment Failure | 4 | 2019 | 2643 | 0.180 |
Why?
|
Situs Inversus | 2 | 2010 | 63 | 0.180 |
Why?
|
Hospital Mortality | 6 | 2021 | 5293 | 0.180 |
Why?
|
Heart Arrest | 1 | 2010 | 1514 | 0.180 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2020 | 1310 | 0.170 |
Why?
|
Risk Factors | 19 | 2021 | 74213 | 0.170 |
Why?
|
Aged, 80 and over | 24 | 2021 | 58984 | 0.170 |
Why?
|
Ischemic Attack, Transient | 2 | 2018 | 882 | 0.160 |
Why?
|
Software | 1 | 2013 | 4434 | 0.160 |
Why?
|
Bone Marrow Transplantation | 1 | 2006 | 2693 | 0.160 |
Why?
|
Septal Occluder Device | 1 | 2019 | 125 | 0.160 |
Why?
|
Nuclear Localization Signals | 1 | 1998 | 77 | 0.150 |
Why?
|
Drug Design | 2 | 2014 | 1048 | 0.150 |
Why?
|
Comorbidity | 7 | 2020 | 10508 | 0.150 |
Why?
|
Prevalence | 6 | 2021 | 15733 | 0.150 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 244 | 0.150 |
Why?
|
Recurrence | 5 | 2024 | 8466 | 0.150 |
Why?
|
Telomerase | 1 | 2003 | 745 | 0.150 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2020 | 710 | 0.150 |
Why?
|
Electrodes | 2 | 2018 | 614 | 0.150 |
Why?
|
Cross-Over Studies | 2 | 2017 | 2079 | 0.150 |
Why?
|
Endocardium | 1 | 2018 | 248 | 0.140 |
Why?
|
Tachycardia, Supraventricular | 1 | 2019 | 273 | 0.140 |
Why?
|
Prospective Studies | 14 | 2019 | 54423 | 0.140 |
Why?
|
Length of Stay | 4 | 2019 | 6426 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 11 | 2015 | 20568 | 0.140 |
Why?
|
Vena Cava, Inferior | 1 | 2020 | 458 | 0.140 |
Why?
|
Myocarditis | 1 | 2024 | 788 | 0.130 |
Why?
|
Critical Pathways | 2 | 2019 | 474 | 0.130 |
Why?
|
Predictive Value of Tests | 9 | 2018 | 15266 | 0.130 |
Why?
|
Stress, Psychological | 1 | 2011 | 4481 | 0.130 |
Why?
|
Warfarin | 3 | 2019 | 1483 | 0.130 |
Why?
|
Cell Nucleus | 3 | 2002 | 2910 | 0.130 |
Why?
|
Phrenic Nerve | 1 | 2015 | 79 | 0.130 |
Why?
|
Secondary Prevention | 2 | 2012 | 1475 | 0.120 |
Why?
|
Patient Care Team | 2 | 2019 | 2521 | 0.120 |
Why?
|
Myocardial Infarction | 3 | 2019 | 11461 | 0.120 |
Why?
|
Data Mining | 1 | 2020 | 551 | 0.120 |
Why?
|
Subtraction Technique | 2 | 2008 | 512 | 0.120 |
Why?
|
Early Diagnosis | 2 | 2016 | 1186 | 0.120 |
Why?
|
Time Factors | 15 | 2020 | 39969 | 0.110 |
Why?
|
Air Pollution, Radioactive | 1 | 2013 | 10 | 0.110 |
Why?
|
Equipment Failure Analysis | 3 | 2013 | 847 | 0.110 |
Why?
|
Emergency Service, Hospital | 5 | 2019 | 7879 | 0.110 |
Why?
|
Ventricular Function, Left | 3 | 2018 | 3879 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 6 | 2014 | 6484 | 0.110 |
Why?
|
Educational Measurement | 1 | 2020 | 1255 | 0.110 |
Why?
|
Respiratory System | 1 | 2017 | 563 | 0.110 |
Why?
|
Therapy, Computer-Assisted | 2 | 2020 | 266 | 0.110 |
Why?
|
Heart Valve Prolapse | 1 | 2012 | 3 | 0.110 |
Why?
|
Educational Status | 1 | 2020 | 2522 | 0.110 |
Why?
|
Intraoperative Care | 1 | 2017 | 767 | 0.110 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12059 | 0.100 |
Why?
|
Temperature | 2 | 2018 | 2226 | 0.100 |
Why?
|
Radiation Monitoring | 1 | 2013 | 103 | 0.100 |
Why?
|
Cardiovascular Diseases | 3 | 2020 | 15502 | 0.100 |
Why?
|
Aortic Valve Stenosis | 2 | 2015 | 2001 | 0.100 |
Why?
|
Myocardium | 3 | 2010 | 4725 | 0.100 |
Why?
|
Electric Impedance | 2 | 2014 | 757 | 0.100 |
Why?
|
Coronary Vessels | 4 | 2007 | 3096 | 0.100 |
Why?
|
Endpoint Determination | 1 | 2014 | 590 | 0.100 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2011 | 71 | 0.090 |
Why?
|
Hyponatremia | 1 | 2014 | 279 | 0.090 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2011 | 30 | 0.090 |
Why?
|
Disease Progression | 4 | 2016 | 13510 | 0.090 |
Why?
|
Echocardiography, Doppler | 4 | 2012 | 897 | 0.090 |
Why?
|
Electric Power Supplies | 1 | 2011 | 96 | 0.090 |
Why?
|
Animals | 21 | 2020 | 168475 | 0.090 |
Why?
|
Sex Factors | 4 | 2015 | 10554 | 0.090 |
Why?
|
Sleep Apnea Syndromes | 1 | 2019 | 975 | 0.090 |
Why?
|
Catheters | 2 | 2011 | 427 | 0.090 |
Why?
|
Quinidine | 1 | 2010 | 52 | 0.090 |
Why?
|
Survival Rate | 4 | 2019 | 12723 | 0.090 |
Why?
|
Massachusetts | 7 | 2013 | 8833 | 0.090 |
Why?
|
Cicatrix | 1 | 2017 | 798 | 0.090 |
Why?
|
Heart Failure, Systolic | 1 | 2012 | 135 | 0.090 |
Why?
|
Pulmonary Atelectasis | 1 | 2011 | 143 | 0.090 |
Why?
|
Tomography, Spiral Computed | 1 | 2012 | 273 | 0.090 |
Why?
|
Bundle of His | 1 | 2010 | 101 | 0.090 |
Why?
|
Circadian Rhythm | 3 | 2019 | 2576 | 0.090 |
Why?
|
Patient Selection | 2 | 2017 | 4244 | 0.090 |
Why?
|
Histamine Antagonists | 1 | 2010 | 92 | 0.090 |
Why?
|
Registries | 4 | 2023 | 8225 | 0.090 |
Why?
|
Quality Indicators, Health Care | 1 | 2020 | 1792 | 0.080 |
Why?
|
Antithrombins | 1 | 2012 | 294 | 0.080 |
Why?
|
Sodium Channel Blockers | 1 | 2010 | 173 | 0.080 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2010 | 239 | 0.080 |
Why?
|
Models, Animal | 2 | 2018 | 2112 | 0.080 |
Why?
|
Administration, Oral | 2 | 2019 | 4021 | 0.080 |
Why?
|
Adult | 22 | 2024 | 221210 | 0.080 |
Why?
|
Calmodulin | 3 | 2000 | 218 | 0.080 |
Why?
|
Coronary Sinus | 1 | 2009 | 84 | 0.080 |
Why?
|
Cryotherapy | 1 | 2009 | 159 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3415 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1367 | 0.080 |
Why?
|
Dogs | 1 | 2013 | 3839 | 0.080 |
Why?
|
Cost of Illness | 1 | 2018 | 1937 | 0.080 |
Why?
|
Arrhythmia, Sinus | 1 | 2008 | 48 | 0.080 |
Why?
|
Tachycardia | 1 | 2010 | 600 | 0.080 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1379 | 0.080 |
Why?
|
Suction | 1 | 2009 | 266 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1213 | 0.080 |
Why?
|
Calcium | 7 | 2019 | 5722 | 0.080 |
Why?
|
Sus scrofa | 2 | 2020 | 428 | 0.070 |
Why?
|
Aging | 3 | 2003 | 8710 | 0.070 |
Why?
|
Syncope | 1 | 2010 | 427 | 0.070 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2012 | 1222 | 0.070 |
Why?
|
Acute Disease | 2 | 2024 | 7237 | 0.070 |
Why?
|
Risk Adjustment | 1 | 2011 | 600 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8527 | 0.070 |
Why?
|
Heart-Assist Devices | 2 | 2015 | 1287 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6312 | 0.070 |
Why?
|
Tachycardia, Sinus | 1 | 2006 | 42 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 2007 | 191 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2014 | 1027 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3242 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 6 | 2011 | 36426 | 0.070 |
Why?
|
Terfenadine | 1 | 2005 | 14 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1979 | 0.070 |
Why?
|
Drug Interactions | 1 | 2010 | 1416 | 0.060 |
Why?
|
Heart Valve Prosthesis | 1 | 2014 | 1462 | 0.060 |
Why?
|
Bronchoscopy | 1 | 2011 | 909 | 0.060 |
Why?
|
Nitroglycerin | 1 | 2006 | 329 | 0.060 |
Why?
|
Hospitals | 1 | 2019 | 3883 | 0.060 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2009 | 353 | 0.060 |
Why?
|
Histamine H1 Antagonists | 1 | 2005 | 100 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2019 | 5493 | 0.060 |
Why?
|
Systems Integration | 1 | 2007 | 426 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4793 | 0.060 |
Why?
|
Boston | 3 | 2015 | 9327 | 0.060 |
Why?
|
Foreign-Body Migration | 1 | 2007 | 219 | 0.060 |
Why?
|
Antipsychotic Agents | 2 | 2010 | 3067 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2018 | 12341 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3802 | 0.060 |
Why?
|
Inpatients | 2 | 2020 | 2548 | 0.060 |
Why?
|
Drug Discovery | 1 | 2012 | 1051 | 0.060 |
Why?
|
Psychometrics | 1 | 2014 | 3065 | 0.060 |
Why?
|
Monitoring, Intraoperative | 1 | 2011 | 942 | 0.060 |
Why?
|
Practice Guidelines as Topic | 3 | 2013 | 7391 | 0.060 |
Why?
|
Radiography, Interventional | 2 | 2011 | 1121 | 0.060 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2005 | 352 | 0.060 |
Why?
|
Magnetics | 1 | 2007 | 599 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2013 | 1796 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2014 | 1553 | 0.060 |
Why?
|
Hemothorax | 1 | 2023 | 57 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2000 | 174 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2220 | 0.050 |
Why?
|
Chest Pain | 1 | 2010 | 1091 | 0.050 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2005 | 329 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 3 | 2010 | 1400 | 0.050 |
Why?
|
Preoperative Care | 2 | 2015 | 2242 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1303 | 0.050 |
Why?
|
Protamines | 1 | 2023 | 112 | 0.050 |
Why?
|
Veins | 1 | 2007 | 768 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2010 | 1423 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2011 | 1161 | 0.050 |
Why?
|
Outpatients | 1 | 2010 | 1597 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2006 | 973 | 0.050 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6815 | 0.050 |
Why?
|
Acute Coronary Syndrome | 2 | 2012 | 2190 | 0.050 |
Why?
|
Quality of Life | 2 | 2014 | 13367 | 0.050 |
Why?
|
Image Enhancement | 1 | 2012 | 2884 | 0.050 |
Why?
|
Diagnosis, Differential | 4 | 2011 | 12973 | 0.050 |
Why?
|
Calcium-Transporting ATPases | 2 | 2005 | 122 | 0.050 |
Why?
|
Severity of Illness Index | 5 | 2014 | 15843 | 0.050 |
Why?
|
Aorta, Thoracic | 1 | 2007 | 1096 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2472 | 0.050 |
Why?
|
Potassium Channels, Calcium-Activated | 1 | 2000 | 43 | 0.050 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2002 | 411 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10212 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 3713 | 0.040 |
Why?
|
Technology Transfer | 1 | 2020 | 42 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14608 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 484 | 0.040 |
Why?
|
Wound Healing | 1 | 2011 | 2805 | 0.040 |
Why?
|
Potassium Channel Blockers | 1 | 2000 | 161 | 0.040 |
Why?
|
Radiography | 2 | 2011 | 6965 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2012 | 12463 | 0.040 |
Why?
|
Burns | 1 | 2011 | 1882 | 0.040 |
Why?
|
Melatonin | 2 | 1997 | 669 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2000 | 233 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 1998 | 18 | 0.040 |
Why?
|
Steam | 1 | 2018 | 33 | 0.040 |
Why?
|
Serine | 2 | 2002 | 831 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2013 | 4485 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 1998 | 73 | 0.040 |
Why?
|
Artifacts | 1 | 2007 | 1911 | 0.040 |
Why?
|
Respiratory Rate | 1 | 2019 | 176 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1530 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2008 | 3769 | 0.040 |
Why?
|
Pulse | 1 | 2018 | 217 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18255 | 0.040 |
Why?
|
Survival Analysis | 2 | 2012 | 10090 | 0.040 |
Why?
|
Pericardiocentesis | 2 | 2008 | 78 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2002 | 1154 | 0.040 |
Why?
|
Reoperation | 3 | 2016 | 4303 | 0.030 |
Why?
|
Tidal Volume | 1 | 2019 | 488 | 0.030 |
Why?
|
Chronic Disease | 2 | 2016 | 9319 | 0.030 |
Why?
|
Phosphorylation | 4 | 2005 | 8321 | 0.030 |
Why?
|
Telomere | 1 | 2003 | 943 | 0.030 |
Why?
|
Ultrasonography | 2 | 2010 | 5971 | 0.030 |
Why?
|
COS Cells | 1 | 1998 | 1130 | 0.030 |
Why?
|
Heart Function Tests | 1 | 2017 | 318 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 1578 | 0.030 |
Why?
|
Hydroquinones | 1 | 1995 | 34 | 0.030 |
Why?
|
Protein Kinases | 1 | 2002 | 1608 | 0.030 |
Why?
|
Neurosecretory Systems | 1 | 1997 | 223 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 502 | 0.030 |
Why?
|
Republic of Korea | 1 | 2017 | 590 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2012 | 2927 | 0.030 |
Why?
|
Health Status Indicators | 2 | 2011 | 970 | 0.030 |
Why?
|
Age Factors | 1 | 2012 | 18399 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3530 | 0.030 |
Why?
|
Phlebography | 2 | 2007 | 326 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1693 | 0.030 |
Why?
|
Materials Testing | 1 | 2018 | 863 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22173 | 0.030 |
Why?
|
Medicare | 2 | 2024 | 6770 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2010 | 1574 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1271 | 0.030 |
Why?
|
Myocytes, Cardiac | 2 | 2019 | 1668 | 0.030 |
Why?
|
Transfection | 2 | 2002 | 5774 | 0.030 |
Why?
|
Pilot Projects | 3 | 2013 | 8633 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2019 | 703 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 7968 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2850 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 913 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 2467 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 822 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 2010 | 4420 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 1998 | 858 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2002 | 13446 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1520 | 0.030 |
Why?
|
Binding Sites | 2 | 2000 | 6056 | 0.030 |
Why?
|
Models, Anatomic | 1 | 2017 | 683 | 0.030 |
Why?
|
Cohort Studies | 5 | 2018 | 41495 | 0.030 |
Why?
|
Chlorides | 1 | 1995 | 665 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2002 | 17635 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2011 | 6228 | 0.030 |
Why?
|
Pain | 1 | 2007 | 5073 | 0.030 |
Why?
|
Exercise Test | 1 | 2020 | 2127 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1682 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2122 | 0.020 |
Why?
|
Hypertension | 1 | 2012 | 8540 | 0.020 |
Why?
|
Depressive Disorder | 2 | 1997 | 3728 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1756 | 0.020 |
Why?
|
Logistic Models | 1 | 2006 | 13255 | 0.020 |
Why?
|
Radiation | 1 | 2010 | 49 | 0.020 |
Why?
|
Hemorrhage | 1 | 2023 | 3424 | 0.020 |
Why?
|
Atrial Function | 1 | 2010 | 99 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 1668 | 0.020 |
Why?
|
Femoral Vein | 1 | 2011 | 153 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2019 | 1198 | 0.020 |
Why?
|
Cardiac Output | 1 | 2012 | 831 | 0.020 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2011 | 186 | 0.020 |
Why?
|
Proteins | 1 | 2005 | 6032 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2395 | 0.020 |
Why?
|
Electromagnetic Phenomena | 1 | 2011 | 161 | 0.020 |
Why?
|
Punctures | 1 | 2011 | 366 | 0.020 |
Why?
|
Esophagoscopy | 1 | 2011 | 396 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2011 | 462 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2011 | 382 | 0.020 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2011 | 344 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1242 | 0.020 |
Why?
|
Pancreas | 1 | 1995 | 1691 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2019 | 2775 | 0.020 |
Why?
|
Cardiology | 1 | 2019 | 1656 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12149 | 0.020 |
Why?
|
Radiometry | 1 | 2013 | 813 | 0.020 |
Why?
|
Needles | 1 | 2011 | 451 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5799 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2011 | 1045 | 0.020 |
Why?
|
Systole | 1 | 2010 | 936 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 6403 | 0.020 |
Why?
|
Rupture | 1 | 2008 | 443 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2007 | 208 | 0.020 |
Why?
|
Apoptosis | 1 | 2003 | 9490 | 0.020 |
Why?
|
Patient Discharge | 1 | 2019 | 3443 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 1995 | 1285 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2011 | 1674 | 0.020 |
Why?
|
Cardiac Tamponade | 1 | 2007 | 175 | 0.020 |
Why?
|
Drug Resistance | 1 | 2011 | 1596 | 0.020 |
Why?
|
Hippocampus | 1 | 1998 | 3766 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9610 | 0.020 |
Why?
|
Troponin T | 1 | 2010 | 780 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2011 | 1086 | 0.010 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2005 | 163 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1998 | 11076 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2010 | 809 | 0.010 |
Why?
|
Protein Phosphatase 1 | 1 | 2005 | 134 | 0.010 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2005 | 128 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2010 | 981 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2011 | 1301 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 12953 | 0.010 |
Why?
|
Device Removal | 1 | 2008 | 630 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3683 | 0.010 |
Why?
|
Transposition of Great Vessels | 1 | 2007 | 581 | 0.010 |
Why?
|
Ionomycin | 1 | 2002 | 110 | 0.010 |
Why?
|
Transcription Factors | 1 | 2002 | 12130 | 0.010 |
Why?
|
Sex Distribution | 1 | 2007 | 2280 | 0.010 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2008 | 607 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9647 | 0.010 |
Why?
|
Cardiomegaly | 1 | 2005 | 590 | 0.010 |
Why?
|
Age Distribution | 1 | 2007 | 2879 | 0.010 |
Why?
|
Signal Transduction | 3 | 2003 | 23447 | 0.010 |
Why?
|
Tetraethylammonium Compounds | 1 | 2000 | 31 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8002 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5872 | 0.010 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channels | 1 | 2000 | 36 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2002 | 389 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2005 | 1069 | 0.010 |
Why?
|
Sarcomeres | 1 | 2002 | 368 | 0.010 |
Why?
|
Fibrosis | 1 | 2007 | 2049 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26129 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2000 | 517 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 59260 | 0.010 |
Why?
|
Neurons | 1 | 1998 | 9463 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2002 | 1463 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2002 | 1699 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2000 | 908 | 0.010 |
Why?
|
Cell Line | 2 | 2002 | 15601 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2000 | 705 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2000 | 1090 | 0.010 |
Why?
|
Chloride Channels | 1 | 1995 | 221 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 22176 | 0.010 |
Why?
|
Mutation | 1 | 1998 | 30053 | 0.010 |
Why?
|
Biological Transport | 1 | 1998 | 2091 | 0.010 |
Why?
|
Lung | 1 | 2011 | 10002 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1998 | 1736 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2005 | 9542 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5841 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88326 | 0.010 |
Why?
|
Cells, Cultured | 2 | 1998 | 18966 | 0.010 |
Why?
|
Cell Membrane | 1 | 2000 | 3687 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 9001 | 0.010 |
Why?
|
Homeostasis | 1 | 2000 | 3323 | 0.010 |
Why?
|
Rats | 1 | 2005 | 23741 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 2002 | 7593 | 0.000 |
Why?
|
Cell Division | 1 | 1995 | 4465 | 0.000 |
Why?
|
Mice | 2 | 2005 | 81539 | 0.000 |
Why?
|
Dexamethasone | 1 | 1992 | 1948 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1992 | 1819 | 0.000 |
Why?
|
Menopause | 1 | 1992 | 1646 | 0.000 |
Why?
|
Bipolar Disorder | 1 | 1992 | 5092 | 0.000 |
Why?
|